A K Dutt, W W Stead. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antitubercular Agents/administration & dosageAntitubercular Agents/adverse effectsAntitubercular Agents/therapeutic useDrug Resistance, MicrobialEthambutol/therapeutic useHumansIsoniazid/adverse effectsIsoniazid/therapeutic useMycobacterium tuberculosis/drug effectsPyrazinamide/therapeutic useRifampin/adverse effectsRifampin/therapeutic useStreptomycin/therapeutic useTuberculosis/drug therapy
Substances: See more » Antitubercular AgentsPyrazinamideEthambutolIsoniazidRifampinStreptomycin
Year: 1982 PMID: 6813386 DOI: 10.1093/infdis/146.5.698
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226